Esperion Therapeutics Inc. logo

Esperion Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

6.10
 
USD
  
0.18
  
(3.04%)
Optionable: Yes  Market Cap: 370 M  90-day average vol: 859,344

Previous close: 5.92  Open: 5.82  Bid: 6.19  Ask: 6.19
52 week range    
3.28   
   14.78
Peers   
RARE / 
BMRN / 
FOLD / 
LXRX / 
PFE / 
Last updated: Monday 8th August 2022
40
MarketXLS Rank marketxls
40
Value marketxls
61
Technical marketxls
21
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMRN

16 B886.389.37

FOLD

3 B-10.59.26

LXRX

0 B-6.73.1

PFE

0.0302298 B15.153.21

RARE

5 B-13.369.79

REGN

66 B9.7622.36
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 2.345


Financials

ESPR Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues0000000148 M228 M78 M
Cost of sales-139000-118000-362000-883000-1 M-592000-48000-1190002 M14 M
Gross operating profit0000000148 M225 M64 M
Selling Gen & administrative expense2 M7 M11 M20 M18 M21 M33 M66 M200 M185 M
Research & development expense8 M16 M25 M30 M58 M148 M171 M176 M147 M106 M
Operating income-10 M-23 M-36 M-50 M-76 M-169 M-205 M-93 M-121 M-227 M
floaterest income0000000000
floaterest expense0000000000
Other income net-52000-2 M1190007760002 M2 M3 M4 M5150004 M
Pre-tax Income (EBT)-12 M-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M
Income taxes0000000000
Net income from total operations-12 M-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M
Minority floaterest0000000000
Total net income-12 M-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-12 M-26 M-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M
Depreciation1390001180003620008830001 M59200048000119000450000624000
Amortization0000000000
Operating income before depreciation (EBITDA)-10 M-25 M-36 M-49 M-74 M-167 M-202 M-89 M-120 M-222 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-21.87-3.31-2.22-2.26-3.33-6.98-7.54-3.59-5.23-9.31
Diluted EPS total-21.87-3.31-2.22-2.26-3.33-6.98-7.54-3.59-5.23-9.31
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!